• ⌘ + K
  • Home
  • 0
    Inbox
Explore
  • Browse All
  • Health
  • FedCiv
  • Defense
  • Events
Work
  • Teaming Hub
  • Watchlists
  • Bookmarks
  • Notes
Research
  • Grants
    • Contracts
    • Vehicles
    • OTAs
    • OTIDVs
    • DLA DIBBS
    • SBIR/STTR
  • Agencies
  • NAICS
  • PSC
  • DOGE Tracker

Federal Contract Awards

10awards

Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.

Awardee
is
WZ5RGEMMQ3W9
Award ID
Description
Recipient
Total Value
Awarding Agency
Funding Agency
Set Aside
NAICS
PSC
Award Date
Start Date
End Date
75N95025F00001
INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. POP: 5/2/2025 - 11/1/2026. N01DA-23-8935ALTASCIENCES CLINICAL KANSAS INC$1,340,462NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHMay 2, 2025May 2, 2025Nov 1, 2026
75N95024F00001
INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935ALTASCIENCES CLINICAL KANSAS INC$1,724,199NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHSep 12, 2024Sep 12, 2024Mar 10, 2027
75N95023F00001
PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893ALTASCIENCES CLINICAL KANSAS INC$1,838,615NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHSep 22, 2023Sep 25, 2023Oct 22, 2025
75F40121C00199
DOSE-FINDING STUDY OF KRATOM ALKALOIDS PILOTALTASCIENCES CLINICAL KANSAS INC$2,370,057FOOD AND DRUG ADMINISTRATIONFOOD AND DRUG ADMINISTRATION—541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTHSep 30, 2021Sep 30, 2021Mar 30, 2025
HHSN271201700056C
IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.ALTASCIENCES CLINICAL KANSAS INC$3,562,513NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541712AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHSep 20, 2017Sep 20, 2017Jul 31, 2025
HHSF223201510138C
IGF::CL::IGF - PROJECT ON PHARMACOKINETICS STUDY OF OPIOID DRUG PRODUCT FOLLOWING INSUFFLATION OF MILLED DRUG PRODUCTSALTASCIENCES CLINICAL KANSAS INC$1,293,840FOOD AND DRUG ADMINISTRATIONFOOD AND DRUG ADMINISTRATION—541690Other Scientific and Technical Consulting ServicesB528SPECIAL STUDIES/ANALYSIS- REGULATORYSep 17, 2015Sep 17, 2015Sep 30, 2019
HHSF22301003T
IGF::CL::IGF - PROJECT ON BIOEQUIVALENCE STUDY OF LAMOTRIGINE EXTENDED RELEASE TABLETS.ALTASCIENCES CLINICAL KANSAS INC$983,066FOOD AND DRUG ADMINISTRATIONFOOD AND DRUG ADMINISTRATION—541990All Other Professional, Scientific, and Technical ServicesB528SPECIAL STUDIES/ANALYSIS- REGULATORYSep 10, 2015Sep 10, 2015Sep 24, 2017
HHSF22301001T
IGF::CL::IGF STUDY TITLE BIOEQUIVALENCE AND CHARACTERIZATION OF GENERIC DRUGS.ALTASCIENCES CLINICAL KANSAS INC$1,477,812FOOD AND DRUG ADMINISTRATIONFOOD AND DRUG ADMINISTRATION—541990All Other Professional, Scientific, and Technical ServicesB528SPECIAL STUDIES/ANALYSIS- REGULATORYSep 12, 2014Sep 12, 2014Dec 31, 2016
HHSF22301002T
IGF::OT::IGF OTHER FUNCTIONS - GENERIC ANTIEPILEPTIC DRUGS BIOEQUIVALENCE STUDIESALTASCIENCES CLINICAL KANSAS INC$744,067FOOD AND DRUG ADMINISTRATIONFOOD AND DRUG ADMINISTRATION—541990All Other Professional, Scientific, and Technical ServicesB528SPECIAL STUDIES/ANALYSIS- REGULATORYSep 20, 2012Sep 20, 2012Feb 15, 2015
HHSN271201200018C
IGF::OT::IGF -- OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENTALTASCIENCES CLINICAL KANSAS INC$9,695,476NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541712AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHSep 14, 2012Sep 14, 2012Jan 30, 2018
Page 1 of 1
  • Previous
  • Next